CarMax reports on the dilemma of buying an EV now versus waiting for better technology, advising consumers to define their ...

Lucid Diagnostics' EsoGuard test may soon gain Medicare coverage, boosting its market potential. Read more here.

On that note, earnings season is upon us and two stood out to me: GM and Tesla. Both companies are facing pressure from ...

The recent discussion about electric vehicles (EVs) centers on industry leader Tesla (TSLA) and how new policies might slow ...

Lucid still has a long road ahead, but it is navigating a clear path as it works toward being sustainably profitable.

Wall Street veteran Jim Cramer recently weighted in on the deal, and his take was surprising to many. He compared Lucid's ...

But when interest rates declined in 2024, Rivian and Lucid didn't bounce back even as investors pivoted back toward more ...

The charging integration is not only a win for current and future Lucid drivers, but also a nod to the industry’s evolving ...

Few music biopics these days provoke and prance like Miloš Forman’s 1984 classic, Amadeus. Commercially, the genre may be in ...

Shares of Lucid Group are pulling back in Thursday afternoon trading. Investors are potentially taking profits after the ...

Tesla Inc.'s core car-making business is facing a deteriorating outlook, providing a major test of Chief Executive Officer ...

Everyone has a different theory about why batteries are a thing again, and almost none of them overlap. What’s indisputable is that investors once again have battery fever.